New Drug Helps Patients With Atrial Fibrillation

The experimental anti-clotting drug apixaban beat aspirin at preventing dangerous clots or strokes in people with the abnormal heart rhythm atrial fibrillation, according to final results of the so-called AVERROES trial.

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
   

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.